2012
DOI: 10.1093/carcin/bgs237
|View full text |Cite
|
Sign up to set email alerts
|

Chromium (VI) induces both bulky DNA adducts and oxidative DNA damage at adenines and guanines in the p53 gene of human lung cells

Abstract: Chromium (VI) [Cr(VI)], a ubiquitous environmental carcinogen, is generally believed to induce mainly mutagenic binary and ternary Cr(III)-deoxyguanosine (dG)-DNA adducts in human cells. However, both adenine (A) and guanine (G) mutations are found in the p53 gene in Cr exposure-related lung cancer. Using UvrABC nuclease and formamidopyrimidine glycosylase (Fpg), and ligation-mediated PCR methods, we mapped the distribution of bulky DNA adducts (BDA) and oxidative DNA damage (ODD) in the p53 gene in Cr(VI)-tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
33
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(35 citation statements)
references
References 34 publications
(57 reference statements)
2
33
0
Order By: Relevance
“…This last mutational spectrum is consistent with the mutagenicity of Cr(III)-derived DNA adducts as detected in single-lesion plasmids replicated in human cells (see above) and differs significantly from the spectra induced by known oxygen radicalproducing agents (H 2 O 2 , Fe 2+ and X-ray) analysed in the same study (Chen and Thilly, 1994). Although Cr(VI) is generally believed to induce dG-DNA adducts, both bulky DNA adducts and oxidative damage at adenines and guanines were recently (Arakawa et al, 2012) detected in the p53 gene in Cr(VI) treated human lung cells. The analysis of the binding sites for the three major cellular Cr forms, namely Cr(III), Cr(VI) and Cr(V), suggested that Cr(VI) induction of lesions at dA and dG residues is likely to be through Cr(V) intermediates.…”
Section: Mutagenic and Cytotoxic Properties Of Cr Adductsmentioning
confidence: 99%
“…This last mutational spectrum is consistent with the mutagenicity of Cr(III)-derived DNA adducts as detected in single-lesion plasmids replicated in human cells (see above) and differs significantly from the spectra induced by known oxygen radicalproducing agents (H 2 O 2 , Fe 2+ and X-ray) analysed in the same study (Chen and Thilly, 1994). Although Cr(VI) is generally believed to induce dG-DNA adducts, both bulky DNA adducts and oxidative damage at adenines and guanines were recently (Arakawa et al, 2012) detected in the p53 gene in Cr(VI) treated human lung cells. The analysis of the binding sites for the three major cellular Cr forms, namely Cr(III), Cr(VI) and Cr(V), suggested that Cr(VI) induction of lesions at dA and dG residues is likely to be through Cr(V) intermediates.…”
Section: Mutagenic and Cytotoxic Properties Of Cr Adductsmentioning
confidence: 99%
“…This coincided with Hill et al (2008) and Banu et al (2011) who detected increase in the total p53 protein and p53 phosphorylation in human colon carcinoma cells and ovarian granulosa cells of chromium treated Sprague-Dawley rats. Arakawa et al (2012) also found mutation of p53 gene in Cr (VI)-treated human lung cells due to induction of oxidative DNA damage through Cr (V) intermediate.…”
Section: Discussionmentioning
confidence: 82%
“…The hydroxyl radicals and hydrogen peroxide produced during the reduction of Cr (VI) could be responsible for negative effects on survival of some stages in the earthworm. Arakawa et al (2012) demonstrated in vitro that Cr (III), Cr (VI) and Cr (V), the three major cellular Cr forms, induced bulky DNA adducts and oxidative DNA damage which contributed to mutagenesis of the p53 gene that leads to lung carcinogenesis.…”
Section: Resultsmentioning
confidence: 99%